NCT06410131View on ClinicalTrials.gov

Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16

PHASE1RecruitingINTERVENTIONAL

Enrollment

68

Participants

Timeline

Start Date

May 27, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2027

Conditions

Solid Tumors

Interventions

DRUG

FTL008.16

IV infusion every 2 weeks

Trial Locations (1)

100021

RECRUITING

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors

lead

Sound Biopharmaceuticals Ltd.

INDUSTRY